Epworth Centre for Immunotherapies and Snowdome Laboratories

Beneficiary Profile

Changing blood cancer treatment. Forever.

Epworth believes that the more we understand, the better we can treat and care for our patients.

Epworth is committed to providing the best possible care for all of our patients. As part of this commitment, we invest in world-class equipment, professional development of our staff, and research to find innovative treatments to improve the lives of our patients and their families.

To this end, the Epworth Centre for Immunotherapies and Snowdome Laboratories was established in 2020, under the direction of internationally recognised haematologist, Professor Miles Prince AM. This centre of excellence leads a number of clinical trials to improve blood cancer treatment so that Australians no longer have to travel abroad to access the most advanced treatment options available.

Every day, more than 50 people in Australia are diagnosed with blood cancer.

While blood cancers are classified as a group, each person has a unique experience and treatment needs.  This is why the Centre is committed to identifying and tailoring innovative, personalised treatments for each and every person with blood cancer.

The Centre is currently running haematology clinical trials to find better treatments for blood cancers and undertaking research in the fields of genomics and cancer immunology.

Epworth established the Autologous Stem Cell Transplantation Service in 2023 - the first in a private hospital in Victoria, and only the second in Australia - to provide this treatment option for patients with lymphoma and multiple myeloma.

This transplant service is a specialised multi-step process with various stages of patient treatment and admissions in the Day Oncology Unit and Ward 2 East at Epworth Freemasons hospital.

This is an important step in realising our main objective – to deliver CAR-T Cell Therapy, one of the most revolutionary advances in medical science in recent years. CAR-T involves manipulating the genetic material (DNA) of the patient’s cancer-fighting white blood cells, so that these ‘armoured’ immune cells can then fight and kill cancer cells.  

The Centre is on the cusp of an exciting future and delighted that Hearts and Minds Investments is partnering in its life-saving work.

Projects and discoveries underway

Supporting innovative research and technologies to find answers for blood cancer treatment. Traditional treatments like chemotherapy often lead to severe side effects and variable outcomes. The Epworth Centre works to improve treatment options through cutting-edge research.

https://www.epworth.org.au/our-services/immunotherapieswww.epworth.org.au
Advancing Medical Research Through
Social Impacts
Advancing Knowledge
Informed Decisions
Health Impacts
Further Reading